PharmaCross: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
PharmaCross
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€503,893
2024 · €921,276-€417,383
Equity
€1.2m
2024 · €6.1m-€4.9m
Cash
€455,154
2024 · €1.8m-€1.3m
Balance sheet total
€3.3m
2024 · €7.4m-€4.1m
Largest movements
Assets
- Cash -€1.3m
down €1.3m (-74.2%), from €1.8m to €455,154
mainly Contributions, distributions and other (-€5.4m) and Current portion of long-term debt (-€124,036)
- Current investments -€999,394
no longer reported in 2025 (was €999,394)
- Tangible fixed assets -€887,035
down €887,035 (-98.2%), from €903,365 to €16,330
of which Land and buildings: -€808,820
- Receivables within one year -€774,471
down €774,471 (-22.7%), from €3.4m to €2.6m
of which Other amounts receivable: -€1.3m
- Financial fixed assets -€255,000
down €255,000 (-100.0%), from €255,100 to €100
Equity and liabilities
- Reserves -€5.3m
down €5.3m (-86.2%), from €6.1m to €840,214
- Trade debts +€856,065
up €856,065 (+72.6%), from €1.2m to €2.0m
- Profit (loss) carried forward +€381,201
new in 2025: €381,201
- Current portion of long-term debt -€124,036
no longer reported in 2025 (was €124,036)
Income statement
- Goods and materials +€380,140
up €380,140 (+2.3%), from €16.7m to €17.0m
of which Purchases: +€427,557
- Services and other goods +€320,912
up €320,912 (+83.9%), from €382,508 to €703,419
- Financial income +€208,137
up €208,137 (+869%), from €23,943 to €232,079
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€921,276
Turnover
-€120,590
Other operating income
-€13,966
Goods and materials
-€380,140
Services and other goods
-€320,912
Depreciation
+€91,917
Write-downs
+€3,223
Other operating charges
-€241
Other operating items
-€101,190
Financial income
+€208,137
Financial charges
+€74,526
Taxes
+€141,853
Result 2025
€503,893
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€2.1m
Investment
+€2.1m
Financing
-€5.5m
Cash 2024
€1.8m
From operations (derived)
+€2.1m
Net result for the year
+€503,893
Depreciation
+€2,950
Stocks and contracts
-€76,313
Receivables within one year
+€774,471
Smaller working-capital items
+€5,406
Trade debts
+€856,065
Investment (derived)
+€2.1m
Investment in fixed assets (net)
+€1.1m
Current investments
+€999,394
Financing
-€5.5m
Current portion of long-term debt
-€124,036
Contributions, distributions and other
-€5.4m
Cash 2025
€455,154
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €7,420,068 | €3,275,421 | -€4.1m | -55.9% |
| Fixed assets | 21/28 | €1,158,465 | €16,430 | -€1.1m | -98.6% |
| Tangible fixed assets | 22/27 | €903,365 | €16,330 | -€887,035 | -98.2% |
| Land and buildings | 22 | €808,820 | - | -€808,820 | |
| Plant, machinery and equipment | 23 | €36,036 | - | -€36,036 | |
| Furniture and vehicles | 24 | €58,508 | €16,330 | -€42,178 | -72.1% |
| Financial fixed assets | 28 | €255,100 | €100 | -€255,000 | -100.0% |
| Affiliated companies | 280/1 | €255,100 | €100 | -€255,000 | -100.0% |
| Participating interests | 280 | €255,100 | €100 | -€255,000 | -100.0% |
| Current assets | 29/58 | €6,261,603 | €3,258,991 | -€3.0m | -48.0% |
| Stocks and contracts in progress | 3 | €88,170 | €164,482 | +€76,313 | +86.6% |
| Stocks | 30/36 | €88,170 | €164,482 | +€76,313 | +86.6% |
| Goods purchased for resale | 34 | €88,170 | €164,482 | +€76,313 | +86.6% |
| Amounts receivable within one year | 40/41 | €3,409,678 | €2,635,207 | -€774,471 | -22.7% |
| Trade receivables | 40 | €1,811,742 | €2,381,993 | +€570,250 | +31.5% |
| Other amounts receivable | 41 | €1,597,936 | €253,214 | -€1.3m | -84.2% |
| Current investments | 50/53 | €999,394 | - | -€999,394 | |
| Other investments | 51/53 | €999,394 | - | -€999,394 | |
| Cash at bank and in hand | 54/58 | €1,761,924 | €455,154 | -€1.3m | -74.2% |
| Deferred charges and accrued income | 490/1 | €2,437 | €4,148 | +€1,711 | +70.2% |
| Total equity and liabilities | 10/49 | €7,420,068 | €3,275,421 | -€4.1m | -55.9% |
| Equity | 10/15 | €6,114,986 | €1,231,195 | -€4.9m | -79.9% |
| Contributions | 10/11 | €18,550 | €9,780 | -€8,770 | -47.3% |
| Reserves | 13 | €6,096,436 | €840,214 | -€5.3m | -86.2% |
| Distributable reserves | 133 | €6,096,436 | €840,214 | -€5.3m | -86.2% |
| Profit (loss) carried forward | 14 | - | €381,201 | +€381,201 | |
| Amounts payable | 17/49 | €1,305,081 | €2,044,227 | +€739,146 | +56.6% |
| Amounts payable within one year | 42/48 | €1,305,081 | €2,044,227 | +€739,146 | +56.6% |
| Current portion of amounts payable after more than one year | 42 | €124,036 | - | -€124,036 | |
| Trade debts | 44 | €1,179,844 | €2,035,910 | +€856,065 | +72.6% |
| Suppliers | 440/4 | €1,179,844 | €2,035,910 | +€856,065 | +72.6% |
| Taxes, remuneration and social security | 45 | €1,201 | €8,317 | +€7,117 | +593% |
| Taxes | 450/3 | €1,201 | €8,317 | +€7,117 | +593% |
| Operating income | 70/76A | €18,429,347 | €18,193,602 | -€235,745 | -1.3% |
| Turnover | 70 | €18,306,608 | €18,186,018 | -€120,590 | -0.7% |
| Other operating income | 74 | €19,739 | €5,774 | -€13,966 | -70.8% |
| Non-recurring operating income | 76A | €103,000 | €1,810 | -€101,190 | -98.2% |
| Operating charges | 60/66A | €17,143,316 | €17,749,469 | +€606,153 | +3.5% |
| Goods for resale, raw materials and consumables | 60 | €16,661,225 | €17,041,366 | +€380,140 | +2.3% |
| Purchases | 600/8 | €16,688,510 | €17,116,067 | +€427,557 | +2.6% |
| Change in stocks: decrease (increase) | 609 | -€27,284 | -€74,701 | -€47,417 | -174% |
| Services and other goods | 61 | €382,508 | €703,419 | +€320,912 | +83.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €94,867 | €2,950 | -€91,917 | -96.9% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €1,611 | -€1,611 | -€3,223 | |
| Other operating charges | 640/8 | €3,105 | €3,346 | +€241 | +7.7% |
| Operating profit (loss) | 9901 | €1,286,031 | €444,133 | -€841,898 | -65.5% |
| Financial income | 75/76B | €23,943 | €232,079 | +€208,137 | +869% |
| Recurring financial income | 75 | €23,943 | €232,079 | +€208,137 | +869% |
| Income from current assets | 751 | €18,001 | €169,925 | +€151,923 | +844% |
| Other financial income | 752/9 | €5,942 | €62,155 | +€56,213 | +946% |
| Financial charges | 65/66B | €78,297 | €3,771 | -€74,526 | -95.2% |
| Recurring financial charges | 65 | €78,297 | €3,771 | -€74,526 | -95.2% |
| Debt charges | 650 | €75,639 | €2,782 | -€72,857 | -96.3% |
| Other financial charges | 652/9 | €2,657 | €989 | -€1,669 | -62.8% |
| Profit (loss) for the period before taxes | 9903 | €1,231,677 | €672,441 | -€559,236 | -45.4% |
| Income taxes | 67/77 | €310,401 | €168,548 | -€141,853 | -45.7% |
| Taxes | 670/3 | €310,401 | €168,548 | -€141,853 | -45.7% |
| Profit (loss) for the period | 9904 | €921,276 | €503,893 | -€417,383 | -45.3% |
| Profit (loss) for the period to be appropriated | 9905 | €921,276 | €503,893 | -€417,383 | -45.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.